These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25979517)

  • 1. (Q)SAR: A Tool for the Toxicologist.
    Steinbach T; Gad-McDonald S; Kruhlak N; Powley M; Greene N
    Int J Toxicol; 2015; 34(4):352-4. PubMed ID: 25979517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the European Chemicals Bureau in promoting the regulatory use of (Q)SAR methods.
    Worth AP; Bassan A; De Bruijn J; Gallegos Saliner A; Netzeva T; Patlewicz G; Pavan M; Tsakovska I; Eisenreich S
    SAR QSAR Environ Res; 2007; 18(1-2):111-25. PubMed ID: 17365963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building on a solid foundation: SAR and QSAR as a fundamental strategy to reduce animal testing.
    Sullivan KM; Manuppello JR; Willett CE
    SAR QSAR Environ Res; 2014; 25(5):357-65. PubMed ID: 24773450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano(Q)SAR: Challenges, pitfalls and perspectives.
    Tantra R; Oksel C; Puzyn T; Wang J; Robinson KN; Wang XZ; Ma CY; Wilkins T
    Nanotoxicology; 2015; 9(5):636-42. PubMed ID: 25211549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perspective of predictive toxicity assessment of in vivo repeated dose toxicity using structural activity relationship].
    Ono A
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):44-9. PubMed ID: 21381395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes.
    Patlewicz G; Simon TW; Rowlands JC; Budinsky RA; Becker RA
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):463-77. PubMed ID: 25707856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives from the NanoSafety Modelling Cluster on the validation criteria for (Q)SAR models used in nanotechnology.
    Puzyn T; Jeliazkova N; Sarimveis H; Marchese Robinson RL; Lobaskin V; Rallo R; Richarz AN; Gajewicz A; Papadopulos MG; Hastings J; Cronin MTD; Benfenati E; Fernández A
    Food Chem Toxicol; 2018 Feb; 112():478-494. PubMed ID: 28943385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Q)SAR modeling and safety assessment in regulatory review.
    Kruhlak NL; Benz RD; Zhou H; Colatsky TJ
    Clin Pharmacol Ther; 2012 Mar; 91(3):529-34. PubMed ID: 22258468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
    Amberg A; Beilke L; Bercu J; Bower D; Brigo A; Cross KP; Custer L; Dobo K; Dowdy E; Ford KA; Glowienke S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Nicolette J; Plaper A; Powley M; Quigley DP; Reddy MV; Spirkl HP; Stavitskaya L; Teasdale A; Weiner S; Welch DS; White A; Wichard J; Myatt GJ
    Regul Toxicol Pharmacol; 2016 Jun; 77():13-24. PubMed ID: 26877192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico methods for toxicity prediction.
    Combes RD
    Adv Exp Med Biol; 2012; 745():96-116. PubMed ID: 22437815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity.
    Aptula AO; Roberts DW
    Chem Res Toxicol; 2006 Aug; 19(8):1097-105. PubMed ID: 16918251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of (Q)SAR models for predicting Ames mutagenicity of aryl azo and benzidine based compounds.
    Kulkarni SA; Barton-Maclaren TS
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2014; 32(1):46-82. PubMed ID: 24598040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating (Q)SAR models, expert systems and read-across approaches for the prediction of developmental toxicity.
    Hewitt M; Ellison CM; Enoch SJ; Madden JC; Cronin MT
    Reprod Toxicol; 2010 Aug; 30(1):147-60. PubMed ID: 20006701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges for computational structure-activity modelling for predicting chemical toxicity: future improvements?
    Combes RD
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1129-40. PubMed ID: 21756202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.
    Powley MW
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):295-300. PubMed ID: 25545315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative PBT screening using (Q)SAR tools within REACH legislation.
    Zachary M; Greenway GM
    SAR QSAR Environ Res; 2009; 20(1-2):145-57. PubMed ID: 19343589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Model for Developmental Toxicity: How to Use QSAR Models and Interpret Their Results.
    Marzo M; Roncaglioni A; Kulkarni S; Barton-Maclaren TS; Benfenati E
    Methods Mol Biol; 2016; 1425():139-61. PubMed ID: 27311466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promises and pitfalls of quantitative structure-activity relationship approaches for predicting metabolism and toxicity.
    Zvinavashe E; Murk AJ; Rietjens IM
    Chem Res Toxicol; 2008 Dec; 21(12):2229-36. PubMed ID: 19548346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the mutagenic potential of chemicals in tobacco products using
    Goel R; Valerio LG
    Toxicol Mech Methods; 2020 Nov; 30(9):672-678. PubMed ID: 32752976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.